EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.23.B1 | medicine | studies on differentiation of primary from secondary effects in the pathogenesis of juvenile and adult forms of Pulmonary alveolar proteinosis | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.16 | cystatin C | physiological inhibitor of cathepsin H | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.16 | Homo sapiens | P09668 | - |
- |
3.4.23.B1 | Homo sapiens | O96009 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.22.16 | alveolus | - |
Homo sapiens | - |
3.4.22.16 | bronchoalveolar lavage fluid | - |
Homo sapiens | - |
3.4.22.16 | lung | - |
Homo sapiens | - |
3.4.23.B1 | bronchoalveolar system | bronchoalveolar lavage fluid (BALF), expression in | Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.23.B1 | additional information | - |
amounts and activities of napsin A studied by immunoblotting and specific substrate cleavage, general defect in napsin A expression or activity not observed as cause for abnormal surfactant accumulation in juvenile pulmonary alveolar proteinosis | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.23.B1 | additional information | napsin A expression analyzed in juvenile and adult forms of Pulmonary alveolar proteinosis (PALP) | Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.23.B1 | napsin A | - |
Homo sapiens |